These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

538 related items for PubMed ID: 7531417

  • 1. Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in the pediatric opsoclonus-myoclonus syndrome.
    Pranzatelli MR, Huang Y, Tate E, Stanley M, Noetzel MJ, Gospe SM, Banasiak K.
    Ann Neurol; 1995 Feb; 37(2):189-97. PubMed ID: 7531417
    [Abstract] [Full Text] [Related]

  • 2. Monoaminergic effects of high-dose corticotropin in corticotropin-responsive pediatric opsoclonus-myoclonus.
    Pranzatelli MR, Huang YY, Tate E, Goldstein DS, Holmes CS, Goldstein EM, Ketner K, Kinast M, Lange BM, Sanz A, Shevell MI, Stanford RE, Taff IP.
    Mov Disord; 1998 May; 13(3):522-8. PubMed ID: 9613746
    [Abstract] [Full Text] [Related]

  • 3. Cerebrospinal fluid neurochemistry in the myoclonic subtype of Alzheimer's disease.
    Kaye JA, May C, Atack JR, Daly E, Sweeney DL, Beal MF, Kaufman S, Milstien S, Friedland RP, Rapoport SI.
    Ann Neurol; 1988 Nov; 24(5):647-50. PubMed ID: 2462403
    [Abstract] [Full Text] [Related]

  • 4. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
    Yoshino K.
    No To Shinkei; 1982 Nov; 34(11):1099-106. PubMed ID: 6186264
    [Abstract] [Full Text] [Related]

  • 5. [Metabolites of neurotransmitters in the cerebrospinal fluid in children].
    Zeman J, Böswart J.
    Cesk Pediatr; 1991 May; 46(5):262-5. PubMed ID: 1716526
    [Abstract] [Full Text] [Related]

  • 6. Cerebrospinal fluid biogenic amine metabolites in children during treatment for acute lymphocytic leukemia.
    Silverstein FS, Hutchinson RJ, Johnston MV.
    Pediatr Res; 1986 Apr; 20(4):285-91. PubMed ID: 2422625
    [Abstract] [Full Text] [Related]

  • 7. Cerebrospinal fluid ACTH and cortisol in opsoclonus-myoclonus: effect of therapy.
    Pranzatelli MR, Chun KY, Moxness M, Tate ED, Allison TJ.
    Pediatr Neurol; 2005 Aug; 33(2):121-6. PubMed ID: 16087057
    [Abstract] [Full Text] [Related]

  • 8. Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid.
    Seifert WE, Foxx JL, Butler IJ.
    Ann Neurol; 1980 Jul; 8(1):38-42. PubMed ID: 6157351
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [The effect of amino acids on neurotransmitter metabolites in the cerebrospinal fluid].
    Zeman J, Böswart J.
    Cas Lek Cesk; 1991 May 24; 130(14):425-7. PubMed ID: 1712669
    [Abstract] [Full Text] [Related]

  • 11. [Age changes in concentrations of monoamines and related substances in the cerebrospinal fluid].
    Takahashi S, Abe T.
    No To Shinkei; 1991 Apr 24; 43(4):331-6. PubMed ID: 1716119
    [Abstract] [Full Text] [Related]

  • 12. Cerebrospinal fluid monoaminergic metabolites are elevated in adults with Down's syndrome.
    Kay AD, Schapiro MB, Riker AK, Haxby JV, Rapoport SI, Cutler NR.
    Ann Neurol; 1987 Apr 24; 21(4):408-11. PubMed ID: 2437853
    [Abstract] [Full Text] [Related]

  • 13. Cerebrospinal fluid oligoclonal bands in childhood opsoclonus-myoclonus.
    Pranzatelli MR, Slev PR, Tate ED, Travelstead AL, Colliver JA, Joseph SA.
    Pediatr Neurol; 2011 Jul 24; 45(1):27-33. PubMed ID: 21723456
    [Abstract] [Full Text] [Related]

  • 14. A prospective study of the association of cerebrospinal fluid monoamine metabolite levels with lethality of suicide attempts in patients with bipolar disorder.
    Sher L, Carballo JJ, Grunebaum MF, Burke AK, Zalsman G, Huang YY, Mann JJ, Oquendo MA.
    Bipolar Disord; 2006 Oct 24; 8(5 Pt 2):543-50. PubMed ID: 17042827
    [Abstract] [Full Text] [Related]

  • 15. Opsoclonus-myoclonus-dysequilibrium syndrome: cytological and immunological dynamics in the serial cerebrospinal fluid in two patients.
    Bartos A, Pitha J.
    J Neurol; 2003 Dec 24; 250(12):1420-5. PubMed ID: 14673573
    [Abstract] [Full Text] [Related]

  • 16. 5-Hydroxyindoleacetic acid and homovanillic acid concentrations in cerebrospinal fluid in patients with Alzheimer's disease, depression and mild cognitive impairment.
    Stuerenburg HJ, Ganzer S, Müller-Thomsen T.
    Neuro Endocrinol Lett; 2004 Dec 24; 25(6):435-7. PubMed ID: 15665806
    [Abstract] [Full Text] [Related]

  • 17. Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state.
    Fujimoto A, Nagao T, Ebara T, Sato M, Otsuki S.
    Biol Psychiatry; 1983 Oct 24; 18(10):1141-52. PubMed ID: 6197099
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Monoamine precursors, transmitters and metabolites in cerebrospinal fluid: a prospective study in healthy male subjects.
    Eklundh T, Eriksson M, Sjöberg S, Nordin C.
    J Psychiatr Res; 1996 Oct 24; 30(3):201-8. PubMed ID: 8884658
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.